Freedom Biosciences is a leading biotechnology platform developing next-generation neuropsychiatric therapeutics, focusing on innovative ketamine-based treatments for mental health disorders. Co-founded by Dr. John Krystal and Dina Burkitbayeva, the company leverages a team of experts to create novel antidepressants, building on over 20 years of research. Their pipeline includes multiple clinical and preclinical programs aimed at addressing treatment-resistant depression and substance use disorders, positioning them as a key player in the evolving mental health therapeutics market.

San Francisco, CA, USA

Freedom Biosciences

Stefano Bernardi

Unruly Capital

Tell us about your professional DNA to get discovered by any company in our network with opportunities relevant to your career goals.

Leverage our network to build your career.

#### Welcome!

Thank you for joining Unrulycap Network!

To help us best support you in your search, please take a few minutes to tell us about what you are looking for in your next role. We’ll use this information to connect you to relevant opportunities in the Unrulycap network as they come up.

You can always update this information later.

Welcome to the Unrulycap talent network

As our companies grow, they look to us to help them find the best talent.

Signal that you'd be interested in working with a Unrulycap company to help us put the right opportunities at great companies on your radar. The choice to pursue a new career move is then up to you.

Your professional information is now visible to our team and companies in our network.
We will be in touch when we find a great opportunity for you at one of our companies.

Thanks for signing up

As our companies grow, they look to us to help them find the best talent.
Signal that you'd be interested in working with a Unrulycap company to help us put the right opportunities at great companies on your radar. The choice to pursue a new career move is then up to you.